Friday, April 5, 2019

Inscripta, With Offices In San Diego, Finds $20M For Series C Funding

Gene editing technology developer Inscripta, which has one of its offices in San Diego, saidt his week that has added another $20M in funding to its Series C round, bringing the round to a total of $105.5M. According to Inscripta, the new funding came from its existing investors, including Venrock, Foresite, Mérieux Développement, Paladin Capital G

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.

---